Published in Women's Health Weekly, July 21st, 2005
The study aims to provide greater insight into the genetic contribution to these three chronic diseases, each a major cause of death, disability, and frailty among postmenopausal women of all races and socioeconomic backgrounds, and to relate these findings to the effects of estrogen plus progestin (E+P) therapy.
WHI, with funding support from the National Heart, Lung and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly